Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 4
2020 8
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
Reply to Rizzatti et al.
van der Bogt RD, van der Wilk BJ, van Lanschot JJB, Spaander MCW. van der Bogt RD, et al. Among authors: van der wilk bj. Endoscopy. 2020 Apr;52(4):317. doi: 10.1055/a-1114-2608. Epub 2020 Mar 25. Endoscopy. 2020. PMID: 32212125 No abstract available.
The optimal neoadjuvant treatment of locally advanced esophageal cancer.
van der Wilk BJ, Eyck BM, Lagarde SM, van der Gaast A, Nuyttens JJME, Wijnhoven BPL, van Lanschot JJB. van der Wilk BJ, et al. J Thorac Dis. 2019 Apr;11(Suppl 5):S621-S631. doi: 10.21037/jtd.2018.11.143. J Thorac Dis. 2019. PMID: 31080638 Free PMC article. Review.
Neoadjuvant chemoradiotherapy for resectable oesophageal cancer.
Eyck BM, van der Wilk BJ, Lagarde SM, Wijnhoven BPL, Valkema R, Spaander MCW, Nuyttens JJME, van der Gaast A, van Lanschot JJB. Eyck BM, et al. Among authors: van der wilk bj. Best Pract Res Clin Gastroenterol. 2018 Oct-Dec;36-37:37-44. doi: 10.1016/j.bpg.2018.11.007. Epub 2018 Nov 22. Best Pract Res Clin Gastroenterol. 2018. PMID: 30551855 Review.
Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trial.
van der Wilk BJ, Eyck BM, Doukas M, Spaander MCW, Schoon EJ, Krishnadath KK, Oostenbrug LE, Lagarde SM, Wijnhoven BPL, Looijenga LHJ, Biermann K, van Lanschot JJB. van der Wilk BJ, et al. Br J Surg. 2020 Dec;107(13):1791-1800. doi: 10.1002/bjs.11760. Epub 2020 Aug 5. Br J Surg. 2020. PMID: 32757307 Free PMC article. Clinical Trial.
Endoscopic ultrasound and fine-needle aspiration for the detection of residual nodal disease after neoadjuvant chemoradiotherapy for esophageal cancer.
van der Bogt RD, van der Wilk BJ, Poley JW, Krishnadath KK, Schoon EJ, Oostenbrug LE, Siersema PD, Vleggaar FP, Bruno MJ, Biermann K, van Lanschot JJB, Spaander MCW. van der Bogt RD, et al. Among authors: van der wilk bj. Endoscopy. 2020 Mar;52(3):186-192. doi: 10.1055/a-1065-1759. Epub 2019 Dec 9. Endoscopy. 2020. PMID: 31816658
Surveillance of Clinically Complete Responders Using Serial 18F-FDG PET/CT Scans in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy.
Valkema MJ, van der Wilk BJ, Eyck BM, Wijnhoven BPL, Spaander MCW, Doukas M, Lagarde SM, Schreurs WMJ, Roef MJ, van Lanschot JJB, Valkema R. Valkema MJ, et al. Among authors: van der wilk bj. J Nucl Med. 2021 Apr;62(4):486-492. doi: 10.2967/jnumed.120.247981. Epub 2020 Sep 4. J Nucl Med. 2021. PMID: 32887759
Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched Study.
van der Wilk BJ, Noordman BJ, Neijenhuis LKA, Nieboer D, Nieuwenhuijzen GAP, Sosef MN, van Berge Henegouwen MI, Lagarde SM, Spaander MCW, Valkema R, Biermann K, Wijnhoven BPL, van der Gaast A, van Lanschot JJB, Doukas M, Nikkessen S, Luyer M, Schoon EJ, Roef MJ, van Lijnschoten I, Oostenbrug LE, Riedl RG, Gisbertz SS, Krishnadath KK, Bennink RJ, Meijer SL; Collaborators:. van der Wilk BJ, et al. Ann Surg. 2019 Oct 4. doi: 10.1097/SLA.0000000000003636. Online ahead of print. Ann Surg. 2019. PMID: 31592898
14 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page